The Effects of Antipsychotics on Prolactin Levels and Women's Menstruation
- PMID: 24490071
- PMCID: PMC3886401
- DOI: 10.1155/2013/502697
The Effects of Antipsychotics on Prolactin Levels and Women's Menstruation
Abstract
Introduction. Typical and atypical antipsychotic agent is currently used for treatment in the majority of patients with psychotic disorders. The aim of this review is to assess antipsychotic induced hyperprolactinaemia and the following menstrual dysfunction that affects fertility, quality of life, and therapeutic compliance of women. Method. For this purpose, Medline, PsychInfo, Cochrane library, and Scopus databases were accessed, with a focus on the publication dates between 1954 and 2012. Research of references was also performed and 78 studies were retrieved and used for the needs of this review. Results. A summary of several antipsychotics as well as frequency rates and data on hyperprolactinaemia and menstrual disorders for different agent is presented. Conclusion. Diverse prevalence rates of hyperprolactinaemia and menstrual abnormalities have been found about each medication among different studies. Menstruation plays an important role for women, thus, understanding, careful assessment, and management of hyperprolactinaemia could enhance their lives, especially when dealing with women that suffer from a psychotic disorder.
Figures
Similar articles
-
Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.Drugs. 2004;64(20):2291-314. doi: 10.2165/00003495-200464200-00003. Drugs. 2004. PMID: 15456328 Review.
-
Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis.J Psychopharmacol. 2012 May;26(5 Suppl):42-51. doi: 10.1177/0269881112442016. Epub 2012 Apr 2. J Psychopharmacol. 2012. PMID: 22472310 Review.
-
Comparative Study of Extrapyramidal Side Effects, Sexual Dysfunctions and Hyperprolactinaemia Using Typical and Atypical Antipsychotic Medications Among Patients with Schizophrenia in Maiduguri.Niger Med J. 2023 Dec 28;64(5):612-626. doi: 10.60787/NMJ-64-5-311. eCollection 2023 Sep-Oct. Niger Med J. 2023. PMID: 38962106 Free PMC article.
-
Prolactin awareness: an essential consideration for physical health in schizophrenia.Eur Neuropsychopharmacol. 2008 May;18 Suppl 2:S108-14. doi: 10.1016/j.euroneuro.2008.02.004. Eur Neuropsychopharmacol. 2008. PMID: 18346598 Review.
-
Antipsychotics-related hyperprolactinaemia among patients with schizophrenia in Maiduguri.S Afr J Psychiatr. 2024 Feb 1;30:2133. doi: 10.4102/sajpsychiatry.v30i0.2133. eCollection 2024. S Afr J Psychiatr. 2024. PMID: 38444408 Free PMC article.
Cited by
-
Association of antipsychotic use with breast cancer: a systematic review and meta-analysis of observational studies with over 2 million individuals.Epidemiol Psychiatr Sci. 2022 Sep 5;31:e61. doi: 10.1017/S2045796022000476. Epidemiol Psychiatr Sci. 2022. PMID: 36059215 Free PMC article.
-
Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents.Int Clin Psychopharmacol. 2015 Mar;30(2):103-8. doi: 10.1097/YIC.0000000000000063. Int Clin Psychopharmacol. 2015. PMID: 25514607 Free PMC article.
-
Risperidone-Induced Amenorrhea in Floridly Psychotic Female.Cureus. 2017 Sep 13;9(9):e1683. doi: 10.7759/cureus.1683. Cureus. 2017. PMID: 29152440 Free PMC article.
-
Combination of UGT1A1 polymorphism and baseline plasma bilirubin levels in predicting the risk of antipsychotic-induced dyslipidemia in schizophrenia patients.Schizophrenia (Heidelb). 2024 May 17;10(1):52. doi: 10.1038/s41537-024-00473-1. Schizophrenia (Heidelb). 2024. PMID: 38760414 Free PMC article.
-
Prolactin related symptoms during risperidone maintenance treatment: results from a prospective, multicenter study of schizophrenia.BMC Psychiatry. 2016 Nov 9;16(1):386. doi: 10.1186/s12888-016-1103-3. BMC Psychiatry. 2016. PMID: 27829454 Free PMC article. Clinical Trial.
References
-
- Dickson RA, Glazer WM. Neuroleptic-induced hyperprolactinaemia. Schizophrenia Research. 1999;(35):575–586. - PubMed
-
- Peuskens J, Sienaert P, de Hert M. Sexual dysfunction: the unspoken side effect of antipsychotics. European Psychiatry. 1998;13(1):23–30. - PubMed
-
- Knegtering H, van der Moolen AEGM, Castelein S, Kluiter H, van den Bosch RJ. What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology. 2003;28(2):109–123. - PubMed
-
- Canuso CM, Goldstein JM, Wojcik J, et al. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Research. 2002;111(1):11–20. - PubMed
-
- Brunelleschi S, Zeppegno P, Risso F, Cattaneo CI, Torre E. Risperidone-associated hyperprolactinemia: evaluation in twenty psychiatric outpatients. Pharmacological Research. 2003;48(4):405–409. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources